A novel mutation of gene in a patient with diazoxide-unresponsive congenital hyperinsulinism
Congenital hyperinsulinism (CHI) is a rare condition that can cause irreversible brain damage during the neonatal period owing to the associated hypoglycemia. Hypoglycemia in CHI occurs secondary to the dysregulation of insulin secretion. CHI has been established as a genetic disorder of islet-cell...
Saved in:
Main Authors: | Ji Sook Park (Author), Hong-Jun Lee (Author), Chan-Hoo Park (Author) |
---|---|
Format: | Book |
Published: |
Korean Pediatric Society,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of octreotide treatment for diazoxide‐unresponsive congenital hyperinsulinism in China
by: Bingyan Cao, et al.
Published: (2020) -
Novel Compound Heterozygous Variants of the <i>ABCC8</i> Gene Warrant Identification of Pancreatic Histology in Infant with Diazoxide-unresponsive Congenital Hyperinsulinism
by: Rana Al Balwi, et al.
Published: (2021) -
Using low-dose octreotide with diazoxide-resistant congenital hyperinsulinism resulting from compound heterozygous mutations in the gene
by: Kyujung Park, et al.
Published: (2022) -
A Novel Intragenic Mutation Associated With Congenital Hyperinsulinism
by: Mustafa Tosur MD, et al.
Published: (2017) -
Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China
by: Aijing Xu, et al.
Published: (2019)